Circulating long noncoding RNAs as novel biomarkers of human diseases

Biomark Med. 2016 Jul;10(7):757-69. doi: 10.2217/bmm-2016-0039. Epub 2016 Jun 27.

Abstract

Long noncoding RNAs (lncRNAs) are a kind of noncoding RNAs which are longer than ˜200 nucleotides, lacking of protein-encoding capacity and are implicated in the pathogenesis of various diseases. Recently, it was demonstrated that lncRNAs could be released into the circulation and be stable in blood. Circulating lncRNAs have been reported to have potential in distinguishing patients from healthy individuals. Therefore, the detection of circulating lncRNAs may be valuable for improving the diagnosis and prognosis of various diseases. This review summarized the current understanding of circulating lncRNAs as novel biomarkers of various human diseases, such as cancer, cardiovascular diseases, nervous system diseases and other diseases, which highlighted the significance of circulating lncRNAs as novel diagnostic and prognostic biomarkers of human diseases.

Keywords: circulating lncRNAs; common diseases; diagnosis; long noncoding RNAs; prognosis.

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury / diagnosis
  • Biomarkers / blood*
  • Biomarkers, Tumor / blood
  • Cardiovascular Diseases / diagnosis*
  • Gene Expression Regulation
  • Humans
  • Neoplasms / diagnosis*
  • Nervous System Diseases / diagnosis*
  • Prognosis
  • RNA, Long Noncoding / blood*

Substances

  • Biomarkers
  • Biomarkers, Tumor
  • RNA, Long Noncoding